Free Trial

OpGen (OPGN) Competitors

OpGen logo

OPGN vs. UPHL, ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, TALKW, and TOIIW

Should you be buying OpGen stock or one of its competitors? The main competitors of OpGen include UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry.

OpGen vs. Its Competitors

UpHealth (NYSE:UPHL) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

56.1% of UpHealth shares are owned by institutional investors. Comparatively, 2.7% of OpGen shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Comparatively, 43.8% of OpGen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, UpHealth and UpHealth both had 1 articles in the media. UpHealth's average media sentiment score of 0.00 beat OpGen's score of -0.71 indicating that UpHealth is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UpHealth
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
OpGen
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative

UpHealth has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, OpGen has a beta of -1.77, meaning that its stock price is 277% less volatile than the S&P 500.

OpGen has lower revenue, but higher earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M-$1.350.00
OpGen$2.67M0.00-$32.67MN/AN/A

UpHealth has a net margin of 0.00% compared to OpGen's net margin of -1,140.36%.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
OpGen -1,140.36%N/A -287.58%

Summary

UpHealth beats OpGen on 6 of the 8 factors compared between the two stocks.

Get OpGen News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPGN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPGN vs. The Competition

MetricOpGenMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$1.23M$5.66B$9.82B
Dividend YieldN/AN/A3.79%4.07%
P/E RatioN/AN/A30.5825.12
Price / SalesN/A1.83462.42114.82
Price / CashN/AN/A37.4059.05
Price / BookN/A0.119.096.18
Net Income-$32.67M-$22.69M$3.25B$264.89M

OpGen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPGN
OpGen
N/AN/AN/AN/A$1K$2.67M0.00100News Coverage
Gap Down
UPHL
UpHealth
0.3473 of 5 stars
$0.00
flat
N/A-99.9%$4K$130M0.001,750News Coverage
ACONW
Aclarion
N/A$0.03
-0.3%
N/A+43.6%$0.00$54.60K0.007Positive News
Gap Up
AONC
American Oncology Network
N/A$11.02
-8.2%
N/A+231.5%$0.00$1.34B0.001,520Gap Down
DHACW
Digital Health Acquisition
N/A$0.05
-9.0%
N/A-69.9%$0.00N/A0.00N/AGap Down
FMS
Fresenius Medical Care AG & Co. KGaA
3.5987 of 5 stars
$24.18
+0.3%
$27.80
+15.0%
+34.2%$0.00$20.63B19.811,384Analyst Forecast
Short Interest ↑
LFMDP
LifeMD
N/A$23.77
+0.1%
N/A+8.1%$0.00$245.56M0.00230Positive News
Short Interest ↓
OTRKP
Ontrak
N/A$0.02
-6.3%
N/A-92.0%$0.00$10.84M0.00250Gap Up
High Trading Volume
PIIIW
P3 Health Partners
N/A$0.01
-9.1%
N/AN/A$0.00$1.49B0.00500News Coverage
Gap Down
TALKW
Talkspace
N/A$0.07
-1.4%
N/A+47.0%$0.00$202.61M0.00500Gap Down
TOIIW
Oncology Institute
N/A$0.16
-1.9%
N/A+392.6%$0.00$403.15M0.00660News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:OPGN) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners